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Purpose of the study
Genetic variations in the enzymes responsible for the
metabolism of efavirenz partially explain inter-individual
variability in serum efavirenz concentrations. In this
cross-sectional study we determined the frequency and
impact on efavirenz plasma concentrations of the
CYP2B6 516G>T and CYP2A6*9 polymorphisms.
Methods
Following informed consent, blood samples were
obtained from 521 adults on efavirenz based ART. Drug
concentrations approximately 12-14h post-dose were
measured using a validated HPLC with UV detection.
Total genomic DNA was extracted by standard metho-
dology and patients were genotyped using real-time
PCR with allelic discrimination.
Results
The frequency of CYP2B6 516G>T and CYP2A6*9 gen-
otypes were GG 29.8%, GT 44.3%, TT 25.9% and CC
91.6%, AC 8.7%, and AA 0.39%, respectively. Both poly-
morphisms were statistically associated with efavirenz
plasma concentrations. Median plasma concentrations
according to CYP2B6 516G>T were 1297, 1833 (P <
0.05) and 2248 (P < 0.001) µg/ml for GG, GT and TT
individuals, respectively. Median plasma concentrations
according to CYP2A6*9 were 1713, 3225 (P < 0.0001),
and 1231 µg/ml for CC, CA and AA individuals, respec-
tively. Median efavirenz concentrations in 268 males
were 1759 µg/ml and in 253 females were 1826µg/ml (P
> 0.05).
Conclusions
Our results show that polymorphisms in CYP2B6 and
CYP2A6 genes are significantly associated with plasma
concentrations of efavirenz in Ghanaian HIV infected
patients. Further studies are now warranted to explore
the potential for pharmacogenetics-directed dose indivi-
dualisation of efavirenz. A prospective phase of the
study is in progress to evaluate the influence of genetic
polymorphisms on efavirenz concentrations and CNS
toxicity.
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